A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
- Conditions
- Alopecia AreataPsoriasisChronic Spontaneous UrticariaAtopic DermatitisHidradenitis SuppurativaVitiligo
- Registration Number
- NCT03661866
- Lead Sponsor
- Target PharmaSolutions, Inc.
- Brief Summary
TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
- Detailed Description
TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
The duration of follow-up for participants enrolled in the EU is limited to 5-years. Those within in US and Canada may consent to indefinite follow-up.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 15000
-
- Adults and children (all ages) with Atopic Dermatitis or other Immune-mediated Inflammatory Skin Conditions been prescribed any dermatologic treatment.
-
- Participant has plans for future visits at the site for continued management of IMISC.
-
- Inability to provide written informed consent/assent.
-
- Subjects participating in any interventional study or trial for IMISC treatment trial at the time of enrollment. Patients may be enrolled in TARGET-DERM once participation in the trial is complete. Note: Participants may be enrolled in other registries or studies where IMISC treatment outcomes are observed and/or reported (such as center-based registries).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate Adverse Events of IMISC and treatment in Clinical Practice 25 Years Enable characterization of IMISC disease activity and comorbid medical conditions over time.
Characterize IMISC Treatment Regimens in Clinical Practice 25 Years Enable characterization of IMISC disease activity and comorbid medical conditions over time.
Evaluate Patient Outcomes in Clinical Practice 25 Years Enable characterization of IMISC disease activity and comorbid medical conditions over time.
- Secondary Outcome Measures
Name Time Method Evaluate Patient Reported Outcome (PRO) measures 25 Years Inform clinical practice by identifying the occurrence and impact of comorbid medical conditions on treatment regimens, utilize patient reported outcomes, and evaluate patient support programs.
Evaluate outcomes related to Patient Support Programs (PSPs) 25 Years Inform clinical practice by identifying the occurrence and impact of comorbid medical conditions on treatment regimens, utilize patient reported outcomes, and evaluate patient support programs.
Evaluate the relationship between IMISC and comorbid medical conditions 25 Years Inform clinical practice by identifying the occurrence and impact of comorbid medical conditions on treatment regimens, utilize patient reported outcomes, and evaluate patient support programs.
Trial Locations
- Locations (63)
Clear Dermatology & Aesthetics Center/Investigative MD
🇺🇸Scottsdale, Arizona, United States
Johnson Dermatology
🇺🇸Fort Smith, Arkansas, United States
University of Arkansas for Medical Sciences
🇺🇸Little Rock, Arkansas, United States
Arkansas Dermatology
🇺🇸Little Rock, Arkansas, United States
First OC Dermatology
🇺🇸Fountain Valley, California, United States
Center for Dermatology Cosmetic and Laser Surgery
🇺🇸Fremont, California, United States
University of California
🇺🇸Irvine, California, United States
University of California - San Diego/Rady Children's Hospital
🇺🇸San Diego, California, United States
George Washington University
🇺🇸Washington, District of Columbia, United States
Feinstein Dermatology and Cosmetic Surgery
🇺🇸Hollywood, Florida, United States
Academic Alliance in Dermatology
🇺🇸Tampa, Florida, United States
Integrated Dermatology of West Palm Beach
🇺🇸West Palm Beach, Florida, United States
Lurie Children's Hospital/Northwestern University
🇺🇸Chicago, Illinois, United States
Dawes Fretzin Dermatology/ Dawes Fretzin Clinical Research Group
🇺🇸Indianapolis, Indiana, United States
The University of Kansas Medical Center
🇺🇸Kansas City, Kansas, United States
Family Allergy and Asthma Research Institute
🇺🇸Louisville, Kentucky, United States
DermAssociates, LCC
🇺🇸Rockville, Maryland, United States
Integrated Dermatology of Massachusetts
🇺🇸Quincy, Massachusetts, United States
University of Massachusetts Medical School
🇺🇸Worcester, Massachusetts, United States
University of Minnesota
🇺🇸Minneapolis, Minnesota, United States
Mayo Clinic
🇺🇸Rochester, Minnesota, United States
Carl Thornblade, MD, PLLC
🇺🇸Missoula, Montana, United States
South Lincoln Dermatology Clinic
🇺🇸Lincoln, Nebraska, United States
Advanced Dermatology of the Midlands
🇺🇸Omaha, Nebraska, United States
Dartmouth-Hitchcock Medical Center
🇺🇸Lebanon, New Hampshire, United States
Windsor Dermatology
🇺🇸East Windsor, New Jersey, United States
Linda Susan Marcus
🇺🇸Wyckoff, New Jersey, United States
Montefiore Medical Center
🇺🇸Bronx, New York, United States
Centurion Dermatology
🇺🇸Brooklyn, New York, United States
The University of Buffalo
🇺🇸Buffalo, New York, United States
Empire Dermatology
🇺🇸East Syracuse, New York, United States
Forest Hills Dermatology Group
🇺🇸Forest Hills, New York, United States
Greenwich Village Dermatology
🇺🇸New York, New York, United States
Ichan School of Medicine
🇺🇸New York, New York, United States
Advanced Allergy & Asthma, PLLC
🇺🇸Rockville Centre, New York, United States
Allergy Partners of Western North Carolina
🇺🇸Asheville, North Carolina, United States
UNC Dermatology
🇺🇸Chapel Hill, North Carolina, United States
Wake Forest University Health Sciences
🇺🇸Winston-Salem, North Carolina, United States
Ohio State University
🇺🇸Columbus, Ohio, United States
Allergy, Asthma & Clinical Research Center
🇺🇸Oklahoma City, Oklahoma, United States
Oregon Health and Science University
🇺🇸Portland, Oregon, United States
Allergy and Clinical Immunology
🇺🇸Pittsburgh, Pennsylvania, United States
The Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States
El Paso Dermatology Center
🇺🇸El Paso, Texas, United States
North Texas Center for Clinical Research
🇺🇸Frisco, Texas, United States
Asthma and Allergy Center
🇺🇸Lewisville, Texas, United States
Center for Clinical Studies
🇺🇸Webster, Texas, United States
Allergy Associates of Utah
🇺🇸Murray, Utah, United States
University of Utah MidValley Dermatology
🇺🇸Murray, Utah, United States
Virginia Commonwealth University
🇺🇸Richmond, Virginia, United States
North Sound Dermatology
🇺🇸Mill Creek, Washington, United States
Spokane Dermatology Clinic
🇺🇸Spokane, Washington, United States
Dermatology Center for Skin Health
🇺🇸Morgantown, West Virginia, United States
Children's Hospital of Wisconsin
🇺🇸Milwaukee, Wisconsin, United States
Skin Centre for Dermatology
🇨🇦Peterborough, Ontario, Canada
York Dermatology Clinic and Research Centre
🇨🇦Richmond Hill, Ontario, Canada
Innovaderm Research, Inc.
🇨🇦Montréal, Quebec, Canada
Saskatoon Dermatology Centre
🇨🇦Saskatoon, Saskatchewan, Canada
Dermatologische Gemeinschaftspraxis Mahlow
🇩🇪Mahlow, Bradenburg, Germany
Dr. Bernhard Korge
🇩🇪Düren, NRW, Germany
UKSH- Institut für Entzündungsmedizin
🇩🇪Lübeck, Schleswig-Holstein, Germany
Hospital Clinic de Barcelona
🇪🇸Barcelona, Spain
Hospital Universitario La Princesa
🇪🇸Madrid, Spain